These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11477455)

  • 1. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
    Weinrib L; Li JH; Donovan J; Huang D; Liu FF
    Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma.
    Li JH; Lax SA; Kim J; Klamut H; Liu FF
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):607-16. PubMed ID: 10078646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line.
    Qi V; Weinrib L; Ma N; Li JH; Klamut H; Liu FF
    Int J Hyperthermia; 2001; 17(1):38-47. PubMed ID: 11212879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
    Li JH; Li P; Klamut H; Liu FF
    Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP; Wolf JK; Price JE
    Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential efficacy of p16 gene therapy for EBV-positive nasopharyngeal carcinoma.
    Li AA; Ng E; Shi W; Lee A; Chia M; Liu TJ; Huang D; O'Sullivan B; Gullane P; Liu FF
    Int J Cancer; 2004 Jun; 110(3):452-8. PubMed ID: 15095314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.
    Pagliaro LC; Keyhani A; Liu B; Perrotte P; Wilson D; Dinney CP
    Urol Oncol; 2003; 21(6):456-62. PubMed ID: 14693272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
    Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME
    Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeted gene therapy for nasopharyngeal carcinoma.
    Li JH; Chia M; Shi W; Ngo D; Strathdee CA; Huang D; Klamut H; Liu FF
    Cancer Res; 2002 Jan; 62(1):171-8. PubMed ID: 11782375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo.
    Kralj M; Pavelić J
    J Cancer Res Clin Oncol; 2003 Aug; 129(8):463-71. PubMed ID: 12884025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model.
    Miyake H; Hara I; Hara S; Arakawa S; Kamidono S
    Urology; 2000 Aug; 56(2):332-6. PubMed ID: 10925118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of electrogenetherapy with p53wt combined with cisplatin on curvival of human tumor cell lines with different p53 status.
    Cemazar M; Grosel A; Glavac D; Kotnik V; Skobrne M; Kranjc S; Mir LM; Andre F; Opolon P; Sersa G
    DNA Cell Biol; 2003 Dec; 22(12):765-75. PubMed ID: 14683587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
    Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
    Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
    Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
    Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional gene therapy with Ad5CMV-p53 enhanced the efficacy of radiotherapy in human prostate cancer cells.
    Sasaki R; Shirakawa T; Zhang ZJ; Tamekane A; Matsumoto A; Sugimura K; Matsuo M; Kamidono S; Gotoh A
    Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1336-45. PubMed ID: 11728695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53.
    Basma H; El-Refaey H; Sgagias MK; Cowan KH; Luo X; Cheng PW
    J Biomed Sci; 2005 Dec; 12(6):999-1011. PubMed ID: 16228292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy.
    Chia MC; Shi W; Li JH; Sanchez O; Strathdee CA; Huang D; Busson P; Klamut HJ; Liu FF
    Mol Ther; 2004 Jun; 9(6):804-17. PubMed ID: 15194047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
    Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
    Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.